Loss of endothelial furin leads to cardiac malformation and early postnatal death

Molecular and Cellular Biology

Volumn 32, Issue 17, 2012, Pages 3382-3391

  Kim, WooJin ^a   Essalmani, Rachid ^a   Szumska, Dorota ^b   Creemers, John W M ^c   Roebroek, Anton J M ^c   D'Orleans Juste, Pedro ^d   Bhattachary, Shoumo ^b   Seidah, Nabil G ^a   Prat, Annik ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; BONE MORPHOGENETIC PROTEIN 4; ENDOTHELIN 1; FURIN; PROTEIN PRECURSOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; ENZYME SUBSTRATE; GENE INACTIVATION; HEART VENTRICLE SEPTUM DEFECT; IN VIVO STUDY; LUNG ENDOTHELIUM; MITRAL VALVE DISEASE; MOUSE; NEWBORN; NEWBORN MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; TRICUSPID VALVE DISEASE; WILD TYPE;

ADRENOMEDULLIN; ANIMALS; ANIMALS, NEWBORN; BONE MORPHOGENETIC PROTEIN 4; CELL PROLIFERATION; CELLS, CULTURED; EMBRYO, MAMMALIAN; ENDOTHELIAL CELLS; ENDOTHELIN-1; FEMALE; FURIN; GENE KNOCKOUT TECHNIQUES; HEART DEFECTS, CONGENITAL; HUMANS; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; TRANSFORMING GROWTH FACTOR BETA1;

MAMMALIA;

EID: 84866280245     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.06331-11     Document Type: Article

References (59)

1. Akhurst RJ, Fitzpatrick DR, Gatherer D, Lehnert SA, Millan FA. 1990. Transforming growth factor betas in mammalian embryogenesis. Prog. Growth Factor Res. 2:153-168.
2. Blais V, et al. 2002. Processing of proendothelin-1 by members of the subtilisin-like pro-protein convertase family. FEBS Lett. 524:43-48.
3. Caron KM, Smithies O. 2001. Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional adrenomedullin gene. Proc. Natl. Acad. Sci. U. S. A. 98:615-619.
4. Constam DB, Robertson EJ. 1999. Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. J. Cell Biol. 144:139-149.
5. Constam DB, Robertson EJ. 2000. SPC4/PACE4 regulates a TGF-beta signaling network during axis formation. Genes Dev. 14:1146-1155.
6. Cui Y, et al. 2001. The activity and signaling range of mature BMP-4 is regulated by sequential cleavage at two sites within the prodomain of the precursor. Genes Dev. 15:2797-2802.
7. Cui Y, Jean F, Thomas G, Christian JL. 1998. BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development. EMBO J. 17:4735-4743.
8. Degnin C, Jean F, Thomas G, Christian JL. 2004. Cleavages within the prodomain direct intracellular trafficking and degradation of mature bone morphogenetic protein-4. Mol. Biol. Cell 15:5012-5020.
9. Denault JB, et al. 1995. Processing of proendothelin-1 by human furin convertase. FEBS Lett. 362:276-280.
10. Dubois CM, et al. 2001. Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme. Am. J. Pathol. 158:305-316.
11. Elagoz A, Benjannet S, Mammarbassi A, Wickham L, Seidah NG. 2002. Biosynthesis and cellular trafficking of the convertase SKI-1/S1P: ectodomain shedding requires SKI-1 activity. J. Biol. Chem. 277:11265-11275.
12. Essalmani R, et al. 2008. In vivo functions of the proprotein convertase PC5/6 during mouse development: Gdf11 is a likely substrate. Proc. Natl. Acad. Sci. U. S. A. 105:5750-5755.
13. Fugere M, et al. 2002. Inhibitory potency and specificity of subtilase-like pro-protein convertase (SPC) prodomains. J. Biol. Chem. 277:7648-7656.
14. Goldman DC, et al 2006. Mutation of an upstream cleavage site in the BMP4 prodomain leads to tissue-specific loss of activity. Development 133:1933-1942.
15. Gurtner GC, et al. 1995. Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev. 9:1-14.
16. Hussain M, Hussain S, Krishin J, Abbasi S. 2010. Presentation of congestive cardiac failure in children with ventricular septal defect. J. Ayub. Med. Coll. Abbottabad. 22:135-138.
17. Inoue A, et al. 1989. The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression. J. Biol. Chem. 264: 14954-14959.
18. Itoh Y, et al. 1988. Cloning and sequence analysis of cDNA encoding the precursor of a human endothelium-derived vasoconstrictor peptide, endothelin: identity of human and porcine endothelin. FEBS Lett. 231:440-444.
19. Jiao K, et al. 2003. An essential role of Bmp4 in the atrioventricular septation of the mouse heart. Genes Dev. 17:2362-2367.
20. Jin W, et al. 2005. Proprotein convertases are responsible for proteolysis and inactivation of endothelial lipase. J. Biol. Chem. 280:36551-36559.
21. Keyes WM, Logan C, Parker E, Sanders EJ. 2003. Expression and function of bone morphogenetic proteins in the development of the embryonic endocardial cushions. Anat. Embryol. (Berl.) 207:135-147.
22. Khatib AM, et al. 2001. Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions. J. Biol. Chem. 276:30686-30693.
23. Kido T, Sawamura T, Masaki T. 1998. The processing pathway of endothelin-1 production. J. Cardiovasc. Pharmacol. 31(Suppl 1):S13-S15.
24. Kisanuki YY, et al. 2010. Low blood pressure in endothelial cell-specific endothelin 1 knockout mice. Hypertension 56:121-128.
25. Kisanuki YY, et al. 2001. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 230:230-242.
26. Kitamura K, et al. 1998. The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma. Biochem. Biophys. Res. Commun. 244:551-555.
27. Kitamura K, et al. 1993. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem. Biophys. Res. Commun. 194:720-725.
28. Kurihara Y, et al. 1995. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. J. Clin. Invest. 96:293-300.
29. Lazure C, et al. 1998. In vitro cleavage of internally quenched fluorogenic human proparathyroid hormone and proparathyroid-related peptide substrates by furin. Generation of a potent inhibitor. J. Biol. Chem. 273: 8572-8580.
30. Louagie E, et al. 2008. Role of furin in granular acidification in the endocrine pancreas: identification of the V-ATPase subunit Ac45 as a candidate substrate. Proc. Natl. Acad. Sci. U. S. A. 105:12319-12324.
31. Madri JA, Pratt BM, Tucker AM. 1988. Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J. Cell Biol. 106: 1375-1384.
32. Marchesi C, et al. 2011. Inactivation of endothelial proprotein convertase 5/6 decreases collagen deposition in the cardiovascular system: role of fibroblast autophagy. J. Mol. Med. 89:1103-1111.
33. Massague J. 1990. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6:597-641.
34. Mccoll BK, et al. 2007. Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2. FASEB J. 21:1088-1098.
35. Noddeland H, Omvik P, Lund-Johansen P, Ofstad J, Aukland K. 1984. Interstitial colloid osmotic and hydrostatic pressures in human subcutaneous tissue during early stages of heart failure. Clin. Physiol. 4:283-297.
36. Pesu M, et al. 2008. T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance. Nature 455:246-250.
37. Remacle AG, et al. 2008. Substrate cleavage analysis of furin and related proprotein convertases. A comparative study. J. Biol. Chem. 283:20897-20906.
38. Roebroek AJ, et al. 2004. Limited redundancy of the proprotein convertase furin in mouse liver. J. Biol. Chem. 279:53442-53450.
39. Roebroek AJ, et al. 1998. Failure of ventral closure and axial rotation in embryos lacking the proprotein convertase furin. Development 125:4863-4876.
40. Seidah NG, Chretien M. 1999. Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res. 848:45-62.
41. Seidah NG, Khatib AM, Prat A. 2006. The proprotein convertases and their implication in sterol and/or lipid metabolism. Biol. Chem. 387:871-877.
42. Seidah NG, et al. 2008. The activation and physiological functions of the proprotein convertases. Int. J. Biochem. Cell Biol. 40:1111-1125.
43. Seidah NG, Prat A. 2002. Precursor convertases in the secretory pathway, cytosol and extracellular milieu. Essays Biochem. 38:79-94.
44. Shull MM, et al. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359:693-699.
45. Siegfried G, et al. 2003. The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J. Clin. Invest. 111: 1723-1732.
46. Siegfried G, et al. 2005. Regulation of the stepwise proteolytic cleavage and secretion of PDGF-B by the proprotein convertases. Oncogene 24: 6925-6935.
47. Siegfried G, Khatib AM, Benjannet S, Chretien M, Seidah NG. 2003. The proteolytic processing of pro-platelet-derived growth factor-A at RRKR(86) by members of the proprotein convertase family is functionally correlated to platelet-derived growth factor-A-induced functions and tumorigenicity. Cancer Res. 63:1458-1463.
48. Solloway MJ, Robertson EJ. 1999. Early embryonic lethality in Bmp5; Bmp7 double mutant mice suggests functional redundancy within the 60A subgroup. Development 126:1753-1768.
49. Sugo S, et al. 1994. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem. Biophys. Res. Commun. 201:1160-1166.
50. Sugo S, et al. 1994. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha. Biochem. Biophys. Res. Commun. 203:719-726.
51. Szumska D, et al. 2008. VACTERL/caudal regression/Currarino syndrome-like malformations in mice with mutation in the proprotein convertase Pcsk5. Genes Dev. 22:1465-1477.
52. Thomas G. 2002. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat. Rev. Mol. Cell Biol. 3:753-766.
53. Thompson NL, et al. 1989. Expression of transforming growth factorbeta 1 in specific cells and tissues of adult and neonatal mice. J. Cell Biol. 108:661-669.
54. Winnier G, Blessing M, Labosky PA, Hogan BL. 1995. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 9:2105-2116.
55. Wu C, Wu F, Pan J, Morser J, Wu Q. 2003. Furin-mediated processing of Pro-C-type natriuretic peptide. J. Biol. Chem. 278:25847-25852.
56. Xu D, et al. 1994. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78:473-485.
57. Yanagisawa M, et al. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415.
58. Yang JT, Rayburn H, Hynes RO. 1995. Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac development. Development 121:549-560.
59. Ying Y, Zhao GQ. 2001. Cooperation of endoderm-derived BMP2 and extraembryonic ectoderm-derived BMP4 in primordial germ cell generation in the mouse. Dev. Biol. 232:484-492.